Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Alleviant Medical announced today that it brought in $90 million to fund the second pivotal trial of its atrial shunt ...

[Image courtesy of Biobot] Biobot Surgical announced today that it received CE mark for its Mona Lisa 2.0 surgical robotic ...

Haemonetics announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A.

Medtronic (NYSE: MDT) says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.

Virtuoso Surgical announced today that it took part in a federal program aiming to bring together surgical robotics and AI.

CMR Surgical announced today that it appointed Massimiliano Colella as its new CEO and as a member of the board of directors.